{"filings":[{"id":1195204,"accession_number":"0001213900-26-070627","cik":1792941,"company_name":"Genvor Inc","ticker":"GNVR","form_type":"8-K","filed_at":"2026-06-22T20:15:22+00:00","items":["1.01","3.02","9.01"],"status":"ready","headline":"Genvor amends financing with Evergreen, receives $333,334 and increases warrant coverage to 1.2M shares","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Deleted Evergreen's registration rights in side letter dated June 17, 2026.","Warrant coverage increased from 600,000 to 1,200,000 shares of common stock.","Received gross proceeds of $333,334 from accelerated second and third tranches.","Fourth tranche of $166,667 at Evergreen's option, expiring at note maturity.","Issued five-year warrant to purchase 300,000 shares at $1.00 per share."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":16590000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":582206,"accession_number":"0001903596-26-000235","cik":1792941,"company_name":"Genvor Inc","ticker":"GNVR","form_type":"8-K","filed_at":"2026-05-21T20:15:19+00:00","items":["5.02","8.01","9.01"],"status":"ready","headline":"Genvor appoints Donald Kalkofen CFO; $14K monthly cash + 575K options, going-concern clause in deferred pay","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Donald Kalkofen appointed CFO effective May 18, 2026; 20+ years biotech/tech CFO experience including IPO at Alpha Cognition.","Cash compensation $6,250/month plus deferred $7,750/month; total $14,000/month from Jan 2027.","Options for 575,000 shares: 425,000 vest monthly over 12 months, 150,000 vest upon successful exchange listing.","Deferred comp due by Dec 31, 2026, but can be delayed if board determines going-concern risk.","Options forfeited if shareholder approval of equity plan not obtained by next annual meeting."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":16590000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":15604,"accession_number":"0001903596-26-000204","cik":1792941,"company_name":"Genvor Inc","ticker":"GNVR","form_type":"8-K","filed_at":"2026-05-11T21:28:52+00:00","items":["5.03","3.02","9.01"],"status":"ready","headline":"Genvor creates Series C Preferred Stock with $300K conversion value, issues share to Brio Advisory","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Series C Preferred Stock designated on May 5, 2026; 4 shares created, no preferential voting/dividends but conversion rights.","Each share converts at $300K divided by stock price if listed on Nasdaq/NYSE American by Apr 14, 2027; otherwise floor of $1.00.","One share of Series C Preferred issued to Brio Advisory Group LLC on May 8, 2026 under Section 4(a)(2) exemption.","Issuance is pursuant to Advisory Agreement dated April 16, 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":16590000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":95498,"accession_number":"0001903596-26-000160","cik":1792941,"company_name":"Genvor Inc","ticker":"GNVR","form_type":"8-K","filed_at":"2026-04-22T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Genvor enters $800K convertible note deal with warrants and advisory pact","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Issued $800,000 convertible promissory note (10% interest, 9-month maturity) to Evergreen Capital Management.","Warrants to purchase up to 600,000 shares at $1.00; 5-year term, cashless exercise.","Purchase price of $666,668 includes 20% OID; first tranche of $166,667 funded on April 16, 2026.","Note convertible at $1.00/share (or 80% of lowest VWAP if default) with 4.99% beneficial ownership cap.","Advisory engagement with Brio Advisory for up to $1.2M in preferred stock upon exchange listing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":16590000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":141763,"accession_number":"0001903596-25-000441","cik":1792941,"company_name":"Genvor Inc","ticker":"GNVR","form_type":"8-K","filed_at":"2025-09-04T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Genvor posts updated September 2025 corporate presentation on investor website","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Presentation added to genvor.com/investors on September 4, 2025.","No specific financial results or material business changes disclosed in the filing.","Presentation is summary information; refer to SEC filings and other public announcements.","Company undertakes no obligation to update the presentation."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":16590000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":194720,"accession_number":"0001903596-24-000651","cik":1792941,"company_name":"Genvor Inc","ticker":"GNVR","form_type":"8-K","filed_at":"2024-11-13T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Chad Pawlak, Sr. elected to Genvor's Board of Directors","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Chad Pawlak, Sr. was elected to the Board of Directors on November 12, 2024.","No other changes to Board or officer positions were disclosed.","Genvor is an emerging growth company based in Henderson, NV."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":16590000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":194719,"accession_number":"0001903596-24-000622","cik":1792941,"company_name":"Genvor Inc","ticker":"GNVR","form_type":"8-K","filed_at":"2024-10-22T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Director Judith S. Miller resigns from Genvor board effective August 7, 2024","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Judith S. Miller resigned from Genvor's Board of Directors on August 7, 2024.","The company released this 8-K on October 22, 2024, over two months after the resignation.","No reason for resignation or replacement director has been disclosed.","Genvor has no securities registered under Section 12(b) of the Exchange Act."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":16590000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":229516,"accession_number":"0001493152-24-022265","cik":1792941,"company_name":"Genvor Inc","ticker":"GNVR","form_type":"8-K","filed_at":"2024-06-03T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Genvor terminates CFO and Chief Business Officer Judith S. Miller effective May 29, 2024","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Interim CFO & CBO Judith S. Miller terminated on May 29, 2024; reason not disclosed.","No successor named; CEO Chad Pawlak continues as CEO.","Company is an emerging growth company with no securities listed on any exchange."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":16590000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":248055,"accession_number":"0001493152-24-010701","cik":1792941,"company_name":"Genvor Inc","ticker":"GNVR","form_type":"8-K","filed_at":"2024-03-21T23:59:59+00:00","items":["4.01","9.01"],"status":"ready","headline":"Genvor dismisses Turner Stone & Co as auditor; new firm Novogradac engaged","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Turner, Stone & Company, LLP dismissed as independent auditor on March 17, 2024.","Prior audit reports for FY2022 and FY2023 included a going concern explanatory paragraph.","Novogradac & Company LLP appointed as new independent auditor effective March 20, 2024.","No disagreements or reportable events occurred with former auditor during covered periods.","Board of Directors approved the change in certifying accountant."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":16590000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":248054,"accession_number":"0001493152-24-003418","cik":1792941,"company_name":"Genvor Inc","ticker":"GNVR","form_type":"8-K","filed_at":"2024-01-23T23:59:59+00:00","items":["1.01","5.02","9.01"],"status":"ready","headline":"Genvor appoints Chad Pawlak CEO, reshuffles executive team; Miller becomes CBO and Interim CFO","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Chad Pawlak appointed CEO with base salary of $300,000/year and up to 30% annual bonus tied to milestones.","Judith Miller resigns as Interim CEO, becomes CBO and Interim CFO with base salary of $180,000/year plus monthly stock grants.","Dr. Jesse Jaynes named Chief Scientific Officer; Dr. Clayton Yates resigns as CSO and becomes scientific advisor.","Executives receive milestone-based equity: Pawlak eligible for up to 4 million shares upon achieving product and regulatory goals.","Indemnification agreements entered into with all officers and directors effective January 17, 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":16590000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":248052,"accession_number":"0001493152-24-002926","cik":1792941,"company_name":"Genvor Inc","ticker":"GNVR","form_type":"8-K/A","filed_at":"2024-01-18T23:59:59+00:00","items":["4.02","9.01"],"status":"ready","headline":"Genvor restates financials for four periods due to $246k liability error","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Non-reliance on financials for Sept 30, 2022, Dec 31, 2022, Mar 31, 2023, June 30, 2023.","Error: incorrectly recorded $246k liability for USDA CRADA extension payment not required.","Overstated current liabilities and net loss by approx. $246k each period.","Independent accountant concurred; letter filed as Exhibit 7.1."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":16590000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":248053,"accession_number":"0001493152-24-002459","cik":1792941,"company_name":"Genvor Inc","ticker":"GNVR","form_type":"8-K","filed_at":"2024-01-16T23:59:59+00:00","items":["4.02"],"status":"ready","headline":"Genvor restates financials for four quarters over $246K liability recording error","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Independent accountant notified Genvor on Jan 9, 2024 that financials for periods ending Sept 2022 through June 2023 should no longer be relied upon.","Error: Company incorrectly recorded a liability for an extension payment on a USDA CRADA contract that was not required; only original amount due had been recorded.","Overstatement of current liabilities and net loss by approximately $246,000 for each of the four quarterly periods.","Genvor intends to file restated financial statements and amend periodic reports immediately after this 8-K."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":16590000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":265520,"accession_number":"0001493152-23-039599","cik":1792941,"company_name":"Genvor Inc","ticker":"GNVR","form_type":"8-K","filed_at":"2023-11-07T23:59:59+00:00","items":["1.01","7.01"],"status":"ready","headline":"Genvor launches new 'Investors' section on its website","summary_kind":"llm","event_type":"other","confidence":"low","bullets":["Launched new website section at www.genvor.com on November 1, 2023.","Section includes information on the company, management, press releases, and SEC filings.","Also includes a new investor presentation for public access.","Company undertakes no duty to update the information on the website.","Filing is for informational purposes and not deemed filed under Exchange Act."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":16590000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":265519,"accession_number":"0001493152-23-036706","cik":1792941,"company_name":"Genvor Inc","ticker":"GNVR","form_type":"8-K","filed_at":"2023-10-10T23:59:59+00:00","items":["1.01","5.02","9.01"],"status":"ready","headline":"Genvor formalizes Interim CEO Judith Miller's compensation with cash and milestone warrants","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Cash fee of $20,000/month retroactive to June 20, 2023, accrued if funds unavailable.","Warrants for 350,000 shares at $0.001/share upon execution; additional warrants up to 1.5M shares on milestones.","Milestones include OTCQB clearance, scientific study results, working agreement, resolution of claims against Bradley White, hiring CEO, and $3M min raise in secondary offering.","Warrant issuance conditioned on average daily trading volume of at least 1,000 shares for 5 consecutive days.","Upon full-time CEO appointment, Miller becomes executive consultant for 6 months at $10,000/month plus 25,000 warrants/month."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":16590000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":282734,"accession_number":"0001493152-23-023622","cik":1792941,"company_name":"Genvor Inc","ticker":"GNVR","form_type":"8-K","filed_at":"2023-07-06T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Genvor terminates CEO Bradley White, appoints Judith S. Miller as Interim CEO","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Bradley White terminated as officer effective June 20, 2023.","Judith S. Miller (age 76), a ~6% shareholder, appointed Interim CEO.","Miller's focus: OTC Link listing, R&D funding, search for permanent CEO.","Terms of Miller's appointment as Interim CEO not yet determined."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":16590000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":357145,"accession_number":"0001477932-22-004808","cik":1792941,"company_name":"Genvor Inc","ticker":"GNVR","form_type":"8-K","filed_at":"2022-07-01T23:59:59+00:00","items":["5.03","5.07","9.01"],"status":"ready","headline":"Allure Worldwide changes name to Genvor Incorporated; shareholders approve charter amendment","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Name changed to Genvor Incorporated effective June 24, 2022 via Certificate of Amendment filed with Nevada.","Amendment approved by written consent of holders of 52.67% of outstanding common shares.","Articles of Incorporation amended and restated in their entirety."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":16590000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":375725,"accession_number":"0001477932-22-004414","cik":1792941,"company_name":"Genvor Inc","ticker":"GNVR","form_type":"8-K","filed_at":"2022-06-15T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Allure Worldwide discloses receipt of valuation report for Genvor Inc. subsidiary","summary_kind":"llm","event_type":"other","confidence":"low","bullets":["Subsidiary Genvor Inc. received a valuation report; no specific valuation figures provided.","The valuation report was furnished as Exhibit 99.1 but full content not included in this filing.","Genvor was recently acquired by Allure Worldwide; deal terms remain undisclosed."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":16590000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":375724,"accession_number":"0001477932-22-004262","cik":1792941,"company_name":"Genvor Inc","ticker":"GNVR","form_type":"8-K","filed_at":"2022-06-09T23:59:59+00:00","items":["2.01","3.02","5.01","5.06","9.01"],"status":"ready","headline":"Allure Worldwide completes reverse acquisition of Genvor; Genvor becomes wholly-owned subsidiary","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["On May 27, 2022, Allure acquired Genvor in a reverse merger; Genvor shareholders received 35,261,871 shares (95% of Allure's outstanding stock).","Genvor develops plant-based defense technology against Aflatoxins; has CRADA with USDA-ARS for corn seed trait development.","Genvor has not yet generated revenue; accumulated deficit of $11.8M and net loss of $3.4M in 2021; going concern doubt raised.","Allure's founding shareholders retain 5% ownership with adjustments to maintain percentage.","Transaction accounted for as recapitalization; Genvor is the accounting acquirer."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.9,"calibrated_materiality_score":0.9,"market_cap_usd":16590000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}